DRMA
Dermata Therapeutics, Inc.
$1.26
-3.08%
2026-05-08
About Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Key Fundamentals
P/E Ratio
0.08
Forward P/E
-0.32
EPS (TTM)
$-8.16
ROE
-194.2%
Profit Margin
0.0%
Price/Book
0.53
Beta
0.67
Market Cap
$5.0M
Avg Volume (10D)
61K
Recent Breakout Signals
No recent breakout signals detected for DRMA.
Recent Price Range (60 Days)
60D High
$2.29
60D Low
$1.10
Avg Volume
1.5M
Latest Close
$1.26
Get breakout alerts for DRMA
Sign up for Breakout Scanner to receive daily notifications when DRMA triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Dermata Therapeutics, Inc. (DRMA) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors DRMA daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. DRMA operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.